11月11日至12日，2025食研汇超级原料大会在杭州隆重举行。微康益生菌的动物双歧杆菌乳亚种BLa80 凭借其卓越的肠道健康功效和坚实的科学循证，成功摘得2025 Very Food年度非常"肠道健康奖"。这一 奖项不仅肯定了BLa80菌株本身的优秀品质，更是对中国自主研发益生菌的高度认可。 在本届超级原料大会上，微康益生菌的动物双歧杆菌乳亚种BLa80荣获2025 Very Food年度非常"肠道健 康"奖，成为会场焦点。 该菌株源自中国四川高原牧区健康母乳样本，于2025年7月2日正式获得国家卫生健康委员会批准，被列 入《可用于婴幼儿食品的菌种名单》的益生菌菌株，实现了中国在婴幼儿益生菌领域"零的突破"，标志 着我国在益生菌研发与应用领域迈出了坚实一步。BLa80的成功不仅是一个菌株的胜利，更是中国益生 菌产业从跟跑到并跑，最终实现领跑的生动写照。 荣耀时刻：中国菌的突破之路 硬核实力：临床循证与智能制造并重 科学循证是微康益生菌研究院的核心基石。据介绍，微康益生菌在全球已经开展了100多项临床研究， 覆盖了代谢健康、肠胃健康、免疫健康等6大健康领域。微康益生菌已经构建了以质量为核心的益生菌 循证研究体 ...

Core Viewpoint - The 2025 Microbiome International Probiotic and Health Summit, co-hosted by Weikang Probiotics and the APC Microbiome Centre of Ireland, emphasizes the theme "Quality Bacteria, Quality Life," focusing on the forefront of probiotic research, evidence-based innovation, and sustainable development strategies in the industry [1][8]. Group 1: Keynote Addresses - Dr. Fang Shuguang, Chairman and Chief Scientist of Weikang Probiotics, and Paul Ross, a member of the American Academy of Microbiology and the Royal Irish Academy, delivered keynote addresses at the summit [5][9]. - The summit highlighted the transition of the global probiotic industry towards a science-based, quality-focused, and industrialized era, advocating for rigorous research design and traceable data for quality control [8][11]. Group 2: Research Reports - Renowned scholars, including Catherine Stanton from the Royal Irish Academy and experts from Fudan University and Suzhou University, presented reports on core topics such as cutting-edge probiotic research, scientific evidence, and future development [13]. - Catherine Stanton discussed the establishment of infant gut microbiota and its impact on host health, emphasizing the role of various factors in gut diversity and the clinical benefits of specific probiotics [14][16]. - Other presentations included innovative approaches to gut health management, the necessity of clinical evidence for probiotics, and the potential of probiotics in cancer treatment and chronic disease management [18][20][22][27]. Group 3: Industry Collaboration and Future Directions - The summit served as a vibrant platform for intellectual exchange, fostering meaningful collaborations and innovations in the probiotic field [11]. - Weikang Probiotics is committed to its mission of "Quality Bacteria, Quality Life," focusing on probiotic strain research, clinical evidence, and large-scale production to provide high-quality probiotic solutions for global consumers [27].